ADHD Assessment & Psychiatry Clinic Dubai by German Diagnostics

Strattera Prescription in Dubai

Strattera (atomoxetine) is a non-stimulant ADHD medicine that is sold in the UAE. A licensed psychiatrist in Dubai reviews your diagnosis, your heart health and your other medicines, and prescribes Strattera when it fits your situation.

Atomoxetine is not on the Emirates Drug Establishment list of controlled medicines, unlike Ritalin, Concerta and Vyvanse.

Adult taking a non-stimulant ADHD capsule with a glass of water, Strattera prescription in Dubai

In short

  • Strattera (atomoxetine) is sold in the UAE, under the brand names Strattera and Apo atomoxetine.
  • Atomoxetine is not on the Emirates Drug Establishment list of controlled and semi-controlled medicines. Methylphenidate and lisdexamfetamine are on it as Psychotropic Schedule II.
  • Atomoxetine is a non-stimulant. It blocks the reuptake of noradrenaline (norepinephrine), a messenger substance in the brain.
  • The full effect of atomoxetine builds over up to 4 weeks, while stimulants act on the first day.
  • In 12 trials with 3,375 adults, atomoxetine reduced ADHD symptoms more than placebo (SMD -0.33, a small to medium effect).
  • Strattera is the first choice for adults with ADHD and a past substance use problem, and a good option with tics or side effects on stimulants.
Not sure you have ADHD? Take the free 2-minute ADHD test.
6 WHO questions, your score in 2 minutes, no sign-up.
Take the free test ›

Can you get Strattera in Dubai?

Yes, Strattera is sold in the UAE, and a licensed psychiatrist in Dubai prescribes it after a confirmed ADHD diagnosis. Drug references list two atomoxetine products for the UAE: Strattera and Apo atomoxetine. Pharmacy stock changes, so the psychiatrist confirms the product at your appointment.

Atomoxetine is not on the Emirates Drug Establishment list of controlled and semi-controlled medicines. Methylphenidate (Ritalin, Concerta) and lisdexamfetamine (Vyvanse) are on that list as Psychotropic Schedule II.

No diagnosis yet? Start with an adult ADHD assessment in Dubai.

Bring:

Psychiatrist discussing Strattera (atomoxetine) with an adult patient at an ADHD clinic in Dubai

What research shows about Strattera in adults

Atomoxetine is the active ingredient of Strattera. The studies below compared atomoxetine with placebo, a dummy pill, in adults with ADHD.

How well does atomoxetine work?

A meta-analysis of 12 trials with 3,375 adults (Cunill, Pharmacoepidemiology and Drug Safety 2013) found that atomoxetine reduced inattention and hyperactivity-impulsivity more than placebo. The standardised mean difference was -0.33, a small to medium effect.

An integrated analysis of all multicentre placebo-controlled trials with 3,374 adults (Asherson, Journal of Psychopharmacology 2014) counted how many people improved. After 10 to 16 weeks, 34.8 percent improved on atomoxetine and 22.3 percent on placebo. After 6 months, the figures were 43.4 and 28.0 percent, so about 4 in 10 adults responded to atomoxetine.

Stimulants show a somewhat larger effect. In a meta-analysis of 11 trials with 1,991 adults (MĂ©száros 2009), Cohen’s d was 0.67 for stimulants and 0.59 for non-stimulants. A value around 0.5 counts as a medium effect.

How long does Strattera take to work?

Strattera reaches its full effect after up to 4 weeks. Atomoxetine starts at 40 mg once a day, in the morning or evening, and rises to 80 mg after 3 to 4 days. The dose stays at 80 mg for about 4 weeks before a further step to the maximum of 100 mg a day. A different medicine is the next step when the effect is still too small 4 weeks later.

One dose of atomoxetine acts for up to 24 hours, so a single dose covers the working day and the evening.

Who is Strattera a good fit for?

Strattera is the preferred first medicine for adults with ADHD and a history of substance use disorder, because atomoxetine has little to no potential for misuse. Atomoxetine is also a good choice with tics or Tourette syndrome and after side effects on stimulants. In randomised trials, atomoxetine did not worsen existing anxiety disorders or tics.

What are the side effects of Strattera?

The most common side effects of atomoxetine in adults are dry mouth, nausea, poor appetite, constipation, sleep problems, dizziness, sweating, lower sex drive, erectile problems and difficulty passing urine.

In the meta-analysis of 12 trials, adults stopped atomoxetine because of side effects more often than placebo (odds ratio 2.57). Blood pressure and heart rate rise slightly on atomoxetine, so both are measured before the first prescription and at every check-up.

Who should not take Strattera?

Strattera is not prescribed together with an MAO inhibitor antidepressant or within 14 days of one, with narrow-angle glaucoma, with a pheochromocytoma (a rare adrenal gland tumour) or with severe heart or blood vessel disease.

Some people break down atomoxetine slowly through the liver enzyme CYP2D6. These slow metabolisers reach about 10 times higher drug levels and start on a lower dose.

Product information for atomoxetine carries a warning about suicidal thoughts in children and teenagers. Studies in adults with ADHD have not shown the same pattern, and mood is checked at every visit.

Compare other options: ADHD medication for adults in Dubai and Ritalin and Concerta prescription in Dubai.

Strattera, guanfacine and travel in the UAE

Atomoxetine is the non-stimulant ADHD medicine with UAE brand names in international drug references.

Is guanfacine (Intuniv) available in the UAE?

Guanfacine (Intuniv) has no UAE brand name in international drug references, and Dubai clinics describe guanfacine as not approved locally. In Dubai, the non-stimulant option for adults with ADHD is atomoxetine.

Do I need a permit to bring Strattera to Dubai?

Atomoxetine does not appear on the Emirates Drug Establishment list of controlled and semi-controlled medicines, the list that sets the permit rules for travellers. The list also states that a medicine missing from it can still fall under the law, so travellers carry the prescription and a doctor’s letter. Full guide: Taking ADHD medication to Dubai.

Can I take Strattera during Ramadan?

One dose of atomoxetine acts for up to 24 hours, so a single dose at suhoor or iftar covers the fasting day. The psychiatrist plans the timing with you. More on timing: ADHD medication during Ramadan.

Frequently asked questions about Strattera in Dubai

Short answers about availability, effect, side effects and pregnancy.

Yes, Strattera (atomoxetine) is sold in the UAE, also as Apo atomoxetine. A licensed psychiatrist prescribes it after a confirmed ADHD diagnosis.

No, atomoxetine is not on the Emirates Drug Establishment list of controlled and semi-controlled medicines (updated 15 September 2022). Methylphenidate and lisdexamfetamine are on that list as Psychotropic Schedule II.

Strattera reaches its full effect after up to 4 weeks, because the dose rises step by step and atomoxetine works gradually. Stimulants act on the first day.

Stimulants reduce ADHD symptoms somewhat more. In 11 trials with 1,991 adults, Cohen’s d was 0.67 for stimulants and 0.59 for non-stimulants. Atomoxetine is preferred when stimulants are not suitable, for example after substance use problems.

The most common side effects are dry mouth, nausea, poor appetite, constipation, sleep problems, sweating and erectile problems. Blood pressure and pulse are checked at every visit.

Data on atomoxetine in pregnancy are limited. A 2024 meta-analysis of 10 studies with about 30,000 pregnant women with ADHD found no clear rise in birth defects with methylphenidate or atomoxetine (odds ratio about 1.1). You and your psychiatrist decide together.

Yes, a Strattera prescription follows a confirmed ADHD diagnosis. Without one, the first step is an adult ADHD assessment in Dubai.

Book your appointment

Two fields are enough, because a short call settles more than a long form. Prefer to write? WhatsApp reaches the clinic phone directly.

Request an appointment

    We reply within clinic hours. Your details are used only to answer your enquiry.

    Sources

    Scroll to Top